Improved Glycemic Control with Insulin Glargine 300 U/mL (Toujeo(®)) in Patients with Type 2 Diabetes: Real-World Effectiveness in Switzerland

INTRODUCTION: Insulin glargine 300 U/mL (Gla-300, Toujeo(®)) is a long-acting, once-daily basal insulin with improved—more stable and smoother—pharmacokinetic and pharmacodynamic profiles compared to insulin glargine 100 U/mL (Gla-100) and insulin degludec (IDeg). These properties have been shown to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiesli, Peter, Schories, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250621/
https://www.ncbi.nlm.nih.gov/pubmed/30302721
http://dx.doi.org/10.1007/s13300-018-0518-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250621/
https://www.ncbi.nlm.nih.gov/pubmed/30302721
http://dx.doi.org/10.1007/s13300-018-0518-x

Ejemplares similares